Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Arteriocyte, Inc. in May, 2019 for $224,994.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM133224-01 | Phase I | 224,994 | May 1, 2019 | |||||||
A SBIR Phase II contract was awarded to Arteriocyte, Inc. in September, 2016 for $810,417.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44AR066427-02 | Phase II | 810,417 | September 1, 2016 | |||||||
A SBIR Phase II contract was awarded to Arteriocyte, Inc. for $1,229,610.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R42HL080856-02 | Phase II | 1,229,610 | ||||||||
A SBIR Phase I contract was awarded to Arteriocyte, Inc. for $283,861.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL110725-01A1 | Phase I | 283,861 | ||||||||
A STTR Phase I contract was awarded to Arteriocyte, Inc. for $310,645.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41EY018784-01 | Phase I | 310,645 | ||||||||
A STTR Phase I contract was awarded to Arteriocyte, Inc. for $142,954.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R42HL080856-01 | Phase I | 142,954 | ||||||||
A STTR Phase II contract was awarded to Arteriocyte, Inc. for $1,229,607.0 USD from the U.S. Department of Health & Human Services. | STTR | 4R42HL080856-02 | Phase II | 1,229,607 | ||||||||
A SBIR Phase I contract was awarded to Arteriocyte, Inc. for $142,954.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R42HL080856-01 | Phase I | 142,954 | ||||||||
A SBIR Phase I contract was awarded to Arteriocyte, Inc. for $281,794.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44HL092706-01 | Phase I | 281,794 | ||||||||
A SBIR Phase I contract was awarded to Arteriocyte, Inc. for $304,943.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA156921-01 | Phase I | 304,943 | ||||||||
A SBIR Phase I contract was awarded to Arteriocyte, Inc. for $219,995.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI092989-01 | Phase I | 219,995 | ||||||||
A SBIR Phase II contract was awarded to Arteriocyte, Inc. for $2,196,210.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44HL092706-02 | Phase II | 2,196,210 |